CA2426580A1 - Mass defect labeling for the determination of oligomer sequences - Google Patents

Mass defect labeling for the determination of oligomer sequences Download PDF

Info

Publication number
CA2426580A1
CA2426580A1 CA002426580A CA2426580A CA2426580A1 CA 2426580 A1 CA2426580 A1 CA 2426580A1 CA 002426580 A CA002426580 A CA 002426580A CA 2426580 A CA2426580 A CA 2426580A CA 2426580 A1 CA2426580 A1 CA 2426580A1
Authority
CA
Canada
Prior art keywords
oligomer
labeled
accordance
atomic number
elements
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002426580A
Other languages
French (fr)
Other versions
CA2426580C (en
Inventor
Luke V. Schneider
Michael P. Hall
Robert Petesch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Target Discovery Inc
Original Assignee
Target Discovery, Inc.
Luke V. Schneider
Michael P. Hall
Robert Petesch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Target Discovery, Inc., Luke V. Schneider, Michael P. Hall, Robert Petesch filed Critical Target Discovery, Inc.
Publication of CA2426580A1 publication Critical patent/CA2426580A1/en
Application granted granted Critical
Publication of CA2426580C publication Critical patent/CA2426580C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848Methods of protein analysis involving mass spectrometry
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869Methods for sequencing
    • C12Q1/6872Methods for sequencing involving mass spectrometry
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01JELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
    • H01J49/00Particle spectrometers or separator tubes
    • H01J49/004Combinations of spectrometers, tandem spectrometers, e.g. MS/MS, MSn
    • H01J49/0045Combinations of spectrometers, tandem spectrometers, e.g. MS/MS, MSn characterised by the fragmentation or other specific reaction
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/10Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/105831Protein or peptide standard or control [e.g., hemoglobin, etc.]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/14Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333Saccharide [e.g., DNA, etc.]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/24Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/25Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25125Digestion or removing interfering materials

Abstract

Mass tagging methods are provided that lead to mass spectrometer detection sensitivities and molecular discriminations that are improved over other methods. In particular the methods are useful for discriminating tagged molecules and fragments of molecules from chemical noise in the mass spectrum.
These mass tagging methods are useful for oligomer sequencing, determining the relative abundances of molecules from different samples, and identifying individual molecules or chemical processing steps in combinatorial chemical libraries. The methods provided are useful for the simultaneous analysis of multiple molecules and reaction mixtures by mass spectrometric methods.

Claims (50)

1. A method for sequencing a terminal portion of an oligomer, comprising:

(a) contacting said oligomer with a labeling moiety to covalently attach a label to the terminus of the oligomer and form a labeled oligomer, said labeling moiety comprising at least one element having an atomic number from 17 to 77, with the proviso that said element is other than sulfur or phosphorus;

(b) fragmenting said labeled oligomer using an enzymatic, chemolytic or mass spectrometric fragmentation method to produce labeled oligomer fragments;
and (c) analyzing said labeled oligomer fragments using a mass spectrometric fragmentation method to determine the sequence of at least two terminal residues.
2. The method of claim 1, wherein said labeling moiety comprises at least one element of atomic number 35 to 63.
3. The method of claim 2, wherein said labeling moiety comprises at least one element of atomic number 39 to 58.
4. The method of claim 2, wherein said labeling moiety comprises at least one element selected from the group consisting of bromine, iodine, europium and yttrium.
5. The method of claim 4, wherein said element is europium.
6. The method of claim 4, wherein said element is yttrium.
7. The method of claim 4, wherein said element is bromine.
8. The method of claim 4, wherein said element is iodine.
9. The method of claim 1, wherein said oligomer is selected from the group consisting of a protein, an oligonucleotide, an oligosaccharide and a lipid.
10. The method of claim 9, wherein said oligomer is an oligonucleotide.
11. The method of claim 9, wherein said sequence is at least three residues.
12. The method of claim 9, wherein said sequence is at least four residues.
13. The method of claim 1, wherein several oligomers, each labeled with a different number of mass defect elements are mixed prior to said fragmenting or analyzing step.
14. A method for sequencing a portion of an oligomer in an oligomer mixture, said method comprising:

(a) contacting said oligomer mixture with a terminus labeling moiety to covalently attach a label to the terminus of said oligomer and form a labeled oligomer mixture, said terminus labeling moiety comprising at least one element having an atomic number from 17 to 77, with the proviso that said element is other than sulfur or phosphorus;

(b) separating individual labeled oligomers in said labeled oligomer mixture;
and (c) analyzing said individual labeled oligomers from step (b) by a mass spectrometric method to determine the sequence of at least two terminus residues.
15. A method in accordance with claim 14, wherein said element has an atomic number of from 35 to 63.
16. A method in accordance with claim 14, wherein said element has an atomic number of from 39 to 58.
17. A method in accordance with claim 14, wherein said element is selected from the group consisting of bromine, iodine, europium and yttrium.
18. A method in accordance with claim 14, further comprising a step prior to step (a) of isolating a group of oligomers from a biological sample.
19. A method in accordance with claim 18, wherein said biological sample is from a diseased tissue sample.
20. A method in accordance with claim 18, wherein said biological sample is from a healthy tissue sample.
21. A method in accordance with claim 14, wherein said separating is conducted by at least one method of capillary electrophoresis of the labeled oligomer mixture.
22. A method in accordance with claim 14, wherein said mass spectrometric method uses ESI-TOF MS.
23. A method for structure and function analysis of an oligomer having a plurality of residues, said method comprising:

(a) contacting said oligomer with a mass defect labeling reagent to differentially label exposed residues and unexposed residues and produce a differentially labeled oligomer, wherein said mass defect labeling reagent comprises at least one element having an atomic number of from 17 to 77 that is other than sulfur or phosphorus;

(b) analyzing said differentially labeled oligomer by a mass spectrometric method to determine sequences of said oligomer that are exposed in the three-dimensional structure and sequences of said oligomer that are unexposed in the three-dimensional structure.
24. A method in accordance with claim 23, wherein said oligomer is a protein, a nucleic acid, or an oligosaccharide.
25. A method in accordance with claim 23, wherein said mass defect labeling reagent comprises at least one element of atomic number 35 to 63.
26. A method in accordance with claim 26, wherein said mass defect labeling reagent is bromine and said oligomer is a protein.
27. A method in accordance with claim 23, wherein said mass defect labeling reagent comprises at least one element of atomic number 39 to 58.
28. A method in accordance with claim 23, wherein said differentially labeled oligomer is fragmented by enzymatic or chemolytic methods prior to step (b).
29. A method in accordance with claim 23, wherein said oligomer is a protein, said mass defect is bromine or iodine and said exposed residues comprises a portion of the tyrosine residues present in said protein.
30. A method in accordance with claim 23, wherein said mass spectrometric method uses ESI-TOF MS.
31. A method in accordance with claim 29, wherein said mass spectrometric method uses ESI-TOF MS.
32. A method for sequencing the terminal portion of an oligomer, comprising:

(a) contacting a first sample of said oligomer with a labeling moiety to covalently attach a label to the terminus of the oligomer and form a labeled oligomer, said labeling moiety having one element with an atomic number from 17 to 77, with the proviso that said element is other than sulfur or phosphorus;

(b) contacting a second sample of said oligomer with a labeling moiety to covalently attach a label to the terminus of the oligomer and form a labeled oligomer, said labeling moiety having two elements with an atomic number from 17 to 77, with the proviso that said elements are other than sulfur or phosphorus;

(c) optionally, repeating step (b) from one to three times with additional samples, wherein the labeling moieties have three, four or five elements, respectively, with an atomic number from 17 to 77, with the proviso that said elements are other than sulfur or phsophorus;

(d) mixing the labeled oligomers from steps (a) through (c);

(e) fragmenting said labeled oligomers using an enzymatic, chemolytic or mass spectrometric fragmentation method to produce labeled oligomer fragments;
and (f) analyzing said labeled oligomer fragments using a mass spectrometric fragmentation method to determine the sequence of at least two terminal residues.
33. The method of claim 32, wherein each of said elements has an atomic number of from 35 to 63.
34. The method of claim 32, wherein each of said elements has an atomic number of from 39 to 58.
35. The method of claim 32, wherein each of said elements is selected from the group consisting of bromine, iodine, europium and yttrium and said oligomer is a protein.
36. The method of claim 32, wherein each of said elements is selected from the group consisting of bromine, iodine, europium and yttrium and said oligomer is an oligonucleotide.
37. The method of claim 32, wherein each of said elements is selected from the group consisting of bromine, iodine, europium and yttrium and said oligomer is an oligosaccharide.
38. A method for sequencing a portion of an oligomer, comprising:

(a) fragmenting aliquots of said oligomer using one or more specific enzymatic or chemolytic fragmentation methods to produce oligomer fragments, wherein a different fragmentation method is applied to each aliquot;

(b) contacting a first aliquot of oligomer fragments with a first labeling moiety to covalently attach said first labeling moiety to the terminus of the oligomer fragments and form labeled oligomer fragments, said first labeling moiety having one element with an atomic number from 17 to 77, with the proviso that said element is other than sulfur or phosphorus;

(c) optionally contacting the other aliquots of oligomer fragments with other distinct labeling moieties to covalently attach said distinct labeling moieties to the termini of the oligomer fragments and form labeled oligomer fragments, said distinct labeling moiety having two or more elements with an atomic number from 17 to 77, with the proviso that said elements are other than sulfur or phosphorus;

(d) optionally mixing the aliquots of labeled oligomer fragments; and (e) analyzing said labeled oligomer fragments using a mass spectrometric fragmentation method to determine the sequence of at least two residues of said oligomer.
39. A method in accordance with claim 38, wherein said oligomer is a lipid.
40. A method in accordance with claim 38, wherein said oligomer is a protein.
41. A method in accordance with claim 38, wherein said oligomer is a nucleic acid.
42. A method in accordance with claim 38, wherein said oligomer is an oligosaccharide.
43. A method in accordance with claim 38, wherein said elements have an atomic number of from 35 to 63.
44. A method in accordance with claim 43, wherein said elements have an atomic number of from 39 to 58.
45. A method for comparing the relative abundances of analytes from two or more samples, comprising:

(a) contacting the analytes of the first sample with with a labeling moiety to covalently attach a label to the analytes and form labeled analytes, said labeling moiety having one element with an atomic number from 17 to 77, with the proviso that said element is other than sulfur or phosphorus;

(b) contacting the analytes of subsequent samples with labeling moieties to covalently attach labels to the analytes in each sample, wherein the labeling moieties used for each subsequent sample contain an additional element with an atomic number from 17 to 77, with the proviso that said elements are other than sulfur or phosphorus;

(c) mixing the aliquots of labeled analytes; and (d) analyzing said labeled analytes using a mass spectrometric fragmentation method to determine the relative abundances of one or more of the analytes between the samples.
46. A method in accordance with claim 45, wherein said elements have an atomic number of from 35 to 63.
47. A method in accordance with claim 45, wherein said elements have an atomic number of from 39 to 58.
48. A method for tagging the elements of chemical libraries, either during synthesis or screening, comprising;

(a) contacting a root tag with a labeling moiety to covalently attach a label to the root tag and form a labeled tag, said labeling moiety having one element with an atomic number from 17 to 77, with the proviso that said element is other than sulfur or phosphorus;

(b) optionally, contacting a root with additional labeling moieties to covalently attach additional labels to the root tag and form a multiply labeled tag, said labeling moiety having one element with an atomic number from 17 to 77, with the proviso that said element is other than sulfur or phosphorus; and (c) analyzing the labeled tag by mass spectrometric methods to determine both its mass and the number of elements with an atomic number from 17 to 77, such that the mass and number of elements identifies the chemical processes to which the specific chemical of the library has been exposed and the identity of the chemical from the library.
49. A method in accordance with claim 48, wherein said elements have an atomic number of from 35 to 63.
50. A method in accordance with claim 48, wherein said elements have an atomic number of from 39 to 58.
CA2426580A 2000-10-19 2001-10-19 Mass defect labeling for the determination of oligomer sequences Expired - Fee Related CA2426580C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US24216500P 2000-10-19 2000-10-19
US24239800P 2000-10-19 2000-10-19
US60/242,165 2000-10-19
US60/242,398 2000-10-19
PCT/US2001/049951 WO2002066952A2 (en) 2000-10-19 2001-10-19 Mass defect labeling for the determination of oligomer sequences

Publications (2)

Publication Number Publication Date
CA2426580A1 true CA2426580A1 (en) 2002-08-29
CA2426580C CA2426580C (en) 2011-09-13

Family

ID=26934884

Family Applications (2)

Application Number Title Priority Date Filing Date
CA2426580A Expired - Fee Related CA2426580C (en) 2000-10-19 2001-10-19 Mass defect labeling for the determination of oligomer sequences
CA000000001A Abandoned CA2425798A1 (en) 2000-10-19 2001-10-19 Methods for determining protein and peptide terminal sequences

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA000000001A Abandoned CA2425798A1 (en) 2000-10-19 2001-10-19 Methods for determining protein and peptide terminal sequences

Country Status (13)

Country Link
US (4) US6962818B2 (en)
EP (3) EP2479578A1 (en)
JP (3) JP4259869B2 (en)
AT (1) ATE552348T1 (en)
AU (2) AU2002246744B2 (en)
CA (2) CA2426580C (en)
DK (1) DK1358458T3 (en)
ES (1) ES2385335T3 (en)
IL (5) IL155518A0 (en)
IS (1) IS6781A (en)
NO (1) NO20033632D0 (en)
PT (1) PT1358458E (en)
WO (2) WO2002066952A2 (en)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6379971B1 (en) 1998-02-24 2002-04-30 Target Discovery, Inc. Methods for sequencing proteins
US6764817B1 (en) 1999-04-20 2004-07-20 Target Discovery, Inc. Methods for conducting metabolic analyses
US6716636B1 (en) 1999-04-20 2004-04-06 Target Discovery, Inc. Methods for sequencing proteins
US7412332B1 (en) 1999-04-23 2008-08-12 Massachusetts Institute Of Technology Method for analyzing polysaccharides
AU8356201A (en) * 2000-08-11 2002-02-25 Agilix Corp Ultra-sensitive detection systems
WO2002066952A2 (en) 2000-10-19 2002-08-29 Target Discovery, Inc Mass defect labeling for the determination of oligomer sequences
US20030078739A1 (en) * 2001-10-05 2003-04-24 Surromed, Inc. Feature list extraction from data sets such as spectra
AU2002365271B2 (en) * 2001-11-06 2008-12-11 Agilix Corporation Sensitive coded detection systems
ITMI20020396A1 (en) * 2002-02-27 2003-08-27 Gian Luigi Gianfranceschi PROCEDURE FOR THE AUTOMATIC DETERMINATION OF THE COMPOSITION AND / OR SEQUENCE OF A POLYMER
WO2004055491A2 (en) * 2002-05-20 2004-07-01 Massachusetts Institute Of Technology Novel method for sequence determination using nmr
AU2003294165A1 (en) * 2002-11-22 2004-06-18 Caprion Pharmaceuticals, Inc. Constellation mapping and uses thereof
JP3817523B2 (en) * 2003-02-14 2006-09-06 株式会社日立製作所 Mass spectrometry data analysis system
JP4532874B2 (en) * 2003-10-07 2010-08-25 キヤノン株式会社 A method of adding additional information to a molecule having a chain structure having an atomic group capable of mass spectrometry as a structural unit and using it as an information recording code
US7105806B2 (en) * 2003-11-26 2006-09-12 Applera Corporation Method and apparatus for de-convoluting a convoluted spectrum
GB0329554D0 (en) * 2003-12-22 2004-01-28 Micromass Ltd Mass spectrometer
US7248360B2 (en) * 2004-04-02 2007-07-24 Ppd Biomarker Discovery Sciences, Llc Polychronic laser scanning system and method of use
JP4393270B2 (en) * 2004-05-21 2010-01-06 株式会社日立ハイテクノロジーズ Mass spectrometer and isomer analysis method
CA2588260A1 (en) * 2004-10-29 2006-05-11 Target Discovery, Inc. Glycan analysis using deuterated glucose
JP2008529035A (en) * 2005-02-03 2008-07-31 パーキンエルマー エルエーエス,インク. Ultra-sensitive detection system using multidimensional signals
EP1894224A4 (en) * 2005-05-27 2011-08-03 Ionwerks Inc Multi-beam ion mobility time-of-flight mass spectrometer with bipolar ion extraction and zwitterion detection
CA2631515C (en) * 2006-02-07 2015-03-31 Mds Sciex, Inc. Chemical noise reduction for mass spectrometry
WO2007093050A1 (en) * 2006-02-13 2007-08-23 Olga Ornatsky Gene expression assays conducted by elemental analysis
US20080319678A1 (en) * 2006-02-15 2008-12-25 University Of Virginia Patent Foundation Mass Tagging for Quantitative Analysis of Biomolecules using 13C Labeled Phenylisocyanate
DE102006035577A1 (en) * 2006-07-27 2008-01-31 Eberhard-Karls-Universität Tübingen Universitätsklinikum Radiopaque conjugate
US7838303B2 (en) * 2006-07-27 2010-11-23 Agilent Technologies, Inc. Peptide derivatization method to increase fragmentation information from MS/MS spectra
US7800057B2 (en) * 2007-06-01 2010-09-21 Perkinelmer Health Sciences, Inc. Atmospheric pressure ion source performance enhancement
US8536520B2 (en) 2007-08-06 2013-09-17 Iroa Technologies Llc Method for generation and use of isotopic patterns in mass spectral data of simple organisms
US7820963B2 (en) 2007-08-06 2010-10-26 Metabolic Alayses, Inc. Method for generation and use of isotopic patterns in mass spectral data of simple organisms
US7820964B2 (en) * 2007-08-06 2010-10-26 Metabolic Analyses, Inc Method for generation and use of stable isotope patterns in mass spectral data
US8969251B2 (en) 2007-10-02 2015-03-03 Methabolic Analyses, Inc. Generation and use of isotopic patterns in mass spectral phenotypic comparison of organisms
US20090095899A1 (en) * 2007-10-16 2009-04-16 Whitehouse Craig M Atmospheric pressure ion source performance enhancement
CN102203292B (en) * 2008-10-29 2014-06-25 南克森制药公司 Sequencing of nucleic acid molecules by mass spectrometry
KR20120089637A (en) 2009-07-22 2012-08-13 에이전시 포 사이언스, 테크놀로지 앤드 리서치 Differentiation Of Isobaric Aminoic Acid And Other Species
US8153961B2 (en) * 2009-08-31 2012-04-10 Thermo Finnigan Llc Methods for acquisition and deductive analysis of mixed fragment peptide mass spectra
PL390797A1 (en) 2010-03-22 2011-09-26 Instytut Chemii Bioorganicznej Polskiej Akademii Nauk Combinatorial library, method for obtaining combinatorial library, method for sequence identification, method for sequencing combinatorial elements of oligonucleotides and/or oligonucleotide analogues libraries, application of the connector to create combinatorial libraries and kit for sequence identification
US9405884B2 (en) 2010-06-16 2016-08-02 Abbvie Inc. Methods and systems for the analysis of protein samples
SG186302A1 (en) 2010-06-16 2013-02-28 Abbott Lab Comparison of protein samples
US9046525B2 (en) * 2010-07-30 2015-06-02 California Institute Of Technology Method of determining the oligomeric state of a protein complex
US8956859B1 (en) 2010-08-13 2015-02-17 Aviex Technologies Llc Compositions and methods for determining successful immunization by one or more vaccines
WO2012137804A1 (en) * 2011-04-04 2012-10-11 株式会社Jclバイオアッセイ Method for determining oligonucleotide sequence
WO2013098609A1 (en) * 2011-12-30 2013-07-04 Dh Technologies Development Pte. Ltd. Systems and methods for sequencing peptides by mass spectrometry
US10593528B2 (en) * 2013-09-23 2020-03-17 Micromass Uk Limited Peak assessment for mass spectrometers
JP2015121500A (en) * 2013-12-25 2015-07-02 株式会社島津製作所 Mass spectroscopy method and mass spectroscope apparatus
US9837255B2 (en) * 2014-07-18 2017-12-05 Thermo Finnigan Llc Methods for mass spectrometry of mixtures of protein or polypeptides using proton transfer reaction
EP3193174B1 (en) 2016-01-14 2018-11-07 Thermo Finnigan LLC Methods for top-down multiplexed mass spectral analysis of mixtures of proteins or polypeptides
EP3193352A1 (en) * 2016-01-14 2017-07-19 Thermo Finnigan LLC Methods for mass spectrometric based characterization of biological molecules
CN111164422B (en) * 2017-08-07 2023-05-02 新加坡科技研究局 Rapid analysis and identification of lipids from liquid chromatography-mass spectrometry (LC-MS) data
US20190172553A1 (en) * 2017-11-08 2019-06-06 Koninklijke Philips N.V. Using k-mers for rapid quality control of sequencing data without alignment
WO2019232520A1 (en) * 2018-06-01 2019-12-05 Cerno Bioscience Llc Mass spectral analysis of large molecules
EA202190550A1 (en) * 2018-08-17 2021-04-23 Ридженерон Фармасьютикалз, Инк. DE NOVO PROTEIN SEQUENCING METHODS
KR102648650B1 (en) * 2018-10-25 2024-03-15 주식회사 엘지화학 Analysis method for polymer end-group
CN113552204A (en) * 2020-04-02 2021-10-26 株式会社岛津制作所 Mass spectrometry method and mass spectrometry system
JP7249980B2 (en) 2020-10-26 2023-03-31 日本電子株式会社 Mass spectrum processing apparatus and method
CN112505328B (en) * 2020-11-02 2024-02-13 武汉金开瑞生物工程有限公司 Isotope labeling kit and labeling method

Family Cites Families (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4351760A (en) 1979-09-07 1982-09-28 Syva Company Novel alkyl substituted fluorescent compounds and polyamino acid conjugates
US4391904A (en) 1979-12-26 1983-07-05 Syva Company Test strip kits in immunoassays and compositions therein
US4830010A (en) 1986-04-04 1989-05-16 Marshall Barry J Methods for the diagnosis of gastrointestinal disorders
US4842701A (en) 1987-04-06 1989-06-27 Battelle Memorial Institute Combined electrophoretic-separation and electrospray method and system
US4994155A (en) * 1988-12-09 1991-02-19 Learonal, Inc. High speed tin, lead or tin/lead alloy electroplating
US5174962A (en) * 1988-06-20 1992-12-29 Genomyx, Inc. Apparatus for determining DNA sequences by mass spectrometry
US4994165A (en) 1989-02-16 1991-02-19 Cornell Research Foundation, Inc. Liquid junction coupling for capillary zone electrophoresis/ion spray spectrometry
CA1340966C (en) * 1989-05-19 2000-04-18 Thomas R. Covey Method of protein analysis
US5100778A (en) 1989-10-03 1992-03-31 Monsanto Company Oligosaccharide sequencing
JPH06506830A (en) * 1991-05-07 1994-08-04 オックスフォード・グリコシステムズ・リミテッド Oligosaccharide sequencing
DE69229914T2 (en) 1991-05-21 2000-04-20 Analytica Of Brandford Inc Process and apparatus for improving the spray ionization of solutes
JPH07507059A (en) 1992-03-25 1995-08-03 デポムド システムズ,インコーポレイテッド Extended release oral drug dosage forms based on alkyl-substituted cellulose
CA2140891A1 (en) 1992-07-24 1994-02-03 David C. Parmelee Peptides useful as internal standards for microsequencing and methods for their use
US5470753A (en) 1992-09-03 1995-11-28 Selectide Corporation Peptide sequencing using mass spectrometry
US5674698A (en) 1992-09-14 1997-10-07 Sri International Up-converting reporters for biological and other assays using laser excitation techniques
US5484926A (en) * 1993-10-07 1996-01-16 Agouron Pharmaceuticals, Inc. HIV protease inhibitors
US6194144B1 (en) * 1993-01-07 2001-02-27 Sequenom, Inc. DNA sequencing by mass spectrometry
US5547835A (en) 1993-01-07 1996-08-20 Sequenom, Inc. DNA sequencing by mass spectrometry
GB9310467D0 (en) 1993-05-20 1993-07-07 Oxford Glycosystems Ltd Glycoconjugates
US5386832A (en) 1993-06-11 1995-02-07 New England Deaconess Hospital Liver function breath test using aromatic amino acids
US5503805A (en) 1993-11-02 1996-04-02 Affymax Technologies N.V. Apparatus and method for parallel coupling reactions
US6017693A (en) * 1994-03-14 2000-01-25 University Of Washington Identification of nucleotides, amino acids, or carbohydrates by mass spectrometry
DE4415480C2 (en) 1994-05-02 1999-09-02 Bruker Daltonik Gmbh Device and method for the mass spectrometric analysis of substance mixtures by coupling capillary electrophoretic separation (CE) with electrospray ionization (ESI)
JP3415682B2 (en) 1994-08-10 2003-06-09 株式会社日立製作所 Capillary electrophoresis / mass spectrometer
US5856082A (en) 1994-08-31 1999-01-05 University Of British Columbia Devices and methods for characterizing proteins and peptides
US5766891A (en) * 1994-12-19 1998-06-16 Sloan-Kettering Institute For Cancer Research Method for molecular cloning and polynucleotide synthesis using vaccinia DNA topoisomerase
US6127134A (en) 1995-04-20 2000-10-03 Carnegie Mellon University Difference gel electrophoresis using matched multiple dyes
US5827659A (en) 1995-05-19 1998-10-27 Perseptive Biosystems, Inc. Methods and apparatus for sequencing polymers using mass spectrometry
US5625184A (en) 1995-05-19 1997-04-29 Perseptive Biosystems, Inc. Time-of-flight mass spectrometry analysis of biomolecules
US5700642A (en) 1995-05-22 1997-12-23 Sri International Oligonucleotide sizing using immobilized cleavable primers
US6004770A (en) 1995-06-07 1999-12-21 Arizona State University Board Of Regents Sample presentation apparatus for mass spectrometry
US5872010A (en) 1995-07-21 1999-02-16 Northeastern University Microscale fluid handling system
US6027890A (en) 1996-01-23 2000-02-22 Rapigene, Inc. Methods and compositions for enhancing sensitivity in the analysis of biological-based assays
US5722642A (en) * 1996-02-16 1998-03-03 Bradshaw; Terry L. Standing privacy fence with a deployable bench
US5800784A (en) 1996-07-09 1998-09-01 Horn; Marcus J. Chemical sample treatment system and cassette, and methods for effecting multistep treatment process
DE69838519T2 (en) 1997-01-15 2008-07-03 Xzillion Gmbh & Co. Kg Mass-labeled hybridization probes
US5953653A (en) 1997-01-28 1999-09-14 Mediaone Group, Inc. Method and system for preventing mobile roaming fraud
GB9710582D0 (en) 1997-05-22 1997-07-16 Oxford Glycosciences Uk Ltd A method for de novo peptide sequence determination
AU9400398A (en) 1997-09-19 1999-04-05 Genetrace Systems, Inc. Dna typing by mass spectrometry with polymorphic dna repeat markers
GB9823646D0 (en) 1997-12-19 1998-12-23 Brax Genomics Ltd Compounds for mass spectrometry
US6379971B1 (en) 1998-02-24 2002-04-30 Target Discovery, Inc. Methods for sequencing proteins
US6428956B1 (en) 1998-03-02 2002-08-06 Isis Pharmaceuticals, Inc. Mass spectrometric methods for biomolecular screening
US5995989A (en) * 1998-04-24 1999-11-30 Eg&G Instruments, Inc. Method and apparatus for compression and filtering of data associated with spectrometry
US6359111B1 (en) * 1998-05-28 2002-03-19 Neorx Corporation Opioid receptor targeting
EP1329513B1 (en) 1998-08-25 2011-12-07 University of Washington Rapid quantitative analysis of proteins or protein function in complex mixtures
US6277644B1 (en) 1999-03-22 2001-08-21 Beckman Coulter, Inc. Method for compositional tag sequencing
WO2000063683A1 (en) 1999-04-20 2000-10-26 Target Discovery, Inc. Polypeptide fingerprinting methods, metabolic profiling, and bioinformatics database
US6677114B1 (en) 1999-04-20 2004-01-13 Target Discovery, Inc. Polypeptide fingerprinting methods and bioinformatics database system
US6391649B1 (en) * 1999-05-04 2002-05-21 The Rockefeller University Method for the comparative quantitative analysis of proteins and other biological material by isotopic labeling and mass spectroscopy
WO2004006831A2 (en) 2002-07-12 2004-01-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method and device for inducing biological processes by micro-organs
US6699846B2 (en) 2000-03-17 2004-03-02 Corixa Corporation Mono- and disaccharides for the treatment of nitric oxide related disorders
WO2002066952A2 (en) 2000-10-19 2002-08-29 Target Discovery, Inc Mass defect labeling for the determination of oligomer sequences
EP1330551A2 (en) 2000-10-30 2003-07-30 Kalobios, Inc. Affinity maturation by competitive selection
US6875668B2 (en) 2000-11-03 2005-04-05 Advanced Micro Devices, Inc. Notched gate structure fabrication
US6750345B2 (en) * 2000-11-07 2004-06-15 Symyx Technologies, Inc. Substituted pyridyl amine catalysts, complexes and compositions
CA2429633A1 (en) 2000-11-16 2002-05-30 Ciphergen Biosystems, Inc. Method for analyzing mass spectra
MXPA03006394A (en) 2001-01-18 2003-10-15 Univ California Minimally invasive glaucoma surgical instrument and method.
KR20030080218A (en) 2001-02-06 2003-10-11 일렉트로닉 아트 아이엔씨. Integration of real-time data into a gaming application
US7074534B2 (en) 2002-07-10 2006-07-11 E. I. Du Pont De Nemours And Company Polymeric charge transport compositions and electronic devices made with such compositions
JP4116351B2 (en) 2002-07-16 2008-07-09 ジヤトコ株式会社 Vehicle control device
GB0216571D0 (en) 2002-07-17 2002-08-28 Celltech R&D Ltd Chemical compounds
US20050147985A1 (en) * 2004-01-05 2005-07-07 Applera Corporation Mixtures of isobarically labeled analytes and fragments ions derived therefrom
JP2005241161A (en) 2004-02-27 2005-09-08 Fujita Corp Consumed energy calculating method in changing variable flow and energy saving diagnosing method

Also Published As

Publication number Publication date
NO20033632L (en) 2003-08-15
IL180304A (en) 2009-12-24
EP1430436A2 (en) 2004-06-23
EP1358458A4 (en) 2009-11-04
US8352193B2 (en) 2013-01-08
IL155281A0 (en) 2003-11-23
EP1358458A2 (en) 2003-11-05
AU2002253825B8 (en) 2007-03-22
CA2426580C (en) 2011-09-13
JP4259869B2 (en) 2009-04-30
AU2002253825B2 (en) 2007-03-15
IS6781A (en) 2003-04-11
PT1358458E (en) 2012-05-24
ES2385335T3 (en) 2012-07-23
ATE552348T1 (en) 2012-04-15
US20060073485A1 (en) 2006-04-06
WO2002066952A3 (en) 2003-09-04
US20070154900A1 (en) 2007-07-05
AU2002246744B2 (en) 2008-04-10
US6962818B2 (en) 2005-11-08
JP2004523751A (en) 2004-08-05
JP2007178443A (en) 2007-07-12
DK1358458T3 (en) 2012-06-18
JP2004519665A (en) 2004-07-02
US20020172961A1 (en) 2002-11-21
JP4020310B2 (en) 2007-12-12
WO2002066952A2 (en) 2002-08-29
JP4467589B2 (en) 2010-05-26
NO20033632D0 (en) 2003-08-15
EP2479578A1 (en) 2012-07-25
IL155281A (en) 2012-05-31
IL155518A (en) 2007-03-08
IL180304A0 (en) 2007-06-03
WO2002061661A2 (en) 2002-08-08
US20040209251A1 (en) 2004-10-21
US7316931B2 (en) 2008-01-08
IL155518A0 (en) 2003-11-23
EP1358458B1 (en) 2012-04-04
WO2002061661A3 (en) 2004-04-08
CA2425798A1 (en) 2002-08-08

Similar Documents

Publication Publication Date Title
CA2426580A1 (en) Mass defect labeling for the determination of oligomer sequences
CN1602422B (en) Methods for isolating and labeling sample molecules and composition
WO2000066792A1 (en) Analysis of differential protein expression
EP1275004B1 (en) Mass labels
AU2001240834A1 (en) Mass labels
CA2542941C (en) Analysis of mass spectral data in the quiet zones and label selection therefor
EP1319954A1 (en) Methods for protein analysis using protein capture arrays
US7029855B1 (en) Radioactive multiplexing analytical methods for biomarkers discovery
US10274485B2 (en) Method for detecting biomolecules
US20020106700A1 (en) Method for analyzing proteins
US20050153298A1 (en) Protein micro-arrays and multi-layered affinity interaction detection
EP1689882B1 (en) Radioactive multiplexing analytical methods
Leitner Chemical derivatization of peptides for quantitative proteomics
KR20010016720A (en) Experimental method of execution experiment of DNA conjunction bonding hybridization in tube of micro well plate
CN115112778A (en) Disease protein biomarker identification method
WO2001046460A3 (en) Method for analyzing nucleic acid sequences
Sequencing Research group/committee reports
Winters et al. The future of cancer diagnostics: proteomics, immunoproteomics, and beyond

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20151019